Peptide Powder Tesamorelin

Tesamorelin powder is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin (also known as Egrifta) is a synthetic form which is used in the treatment of HIV-associated lipodystrophy.
Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism.
4. Tesamorelin Benefits:

Increases natural productions of HGH (human growth hormone)
Increases IGF-1 (Insulin Growth Factor – 1) without altering glucose parameters
Reduced triglycerides
Reduced Visceral Adipose Tissue (VAT)
Reduced Carotid Intima Media Size (cIMT)
Improved cognition in adults over the age of 60.
5. Tesamorelin Dosage:

The recommended dose of Tesamorelin is 2 mg injected subcutaneously once a day.
The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.